Table of Content

1 Autologous Cell Therapy Products Market Overview
1.1 Product Overview and Scope of Autologous Cell Therapy Products
1.2 Autologous Cell Therapy Products Segment by Type
1.2.1 Global Autologous Cell Therapy Products Market Value Comparison by Type (2024-2034)
1.2.2 Autologous Stem Cell Transplants
1.2.3 Autologous T Cell Therapies
1.2.4 Platelet-Rich Plasma (PRP) Therapy
1.2.5 Others
1.3 Autologous Cell Therapy Products Segment by Application
1.3.1 Global Autologous Cell Therapy Products Market Value by Application: (2024-2034)
1.3.2 Cancer
1.3.3 Hemophilia
1.3.4 Others
1.4 Global Autologous Cell Therapy Products Market Size Estimates and Forecasts
1.4.1 Global Autologous Cell Therapy Products Revenue 2018-2029
1.4.2 Global Autologous Cell Therapy Products Sales 2018-2029
1.4.3 Global Autologous Cell Therapy Products Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Autologous Cell Therapy Products Market Competition by Manufacturers
2.1 Global Autologous Cell Therapy Products Sales Market Share by Manufacturers (2018-2024)
2.2 Global Autologous Cell Therapy Products Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Autologous Cell Therapy Products Average Price by Manufacturers (2018-2024)
2.4 Global Autologous Cell Therapy Products Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Autologous Cell Therapy Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autologous Cell Therapy Products, Product Type & Application
2.7 Autologous Cell Therapy Products Market Competitive Situation and Trends
2.7.1 Autologous Cell Therapy Products Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Autologous Cell Therapy Products Players Market Share by Revenue
2.7.3 Global Autologous Cell Therapy Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Autologous Cell Therapy Products Retrospective Market Scenario by Region
3.1 Global Autologous Cell Therapy Products Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Autologous Cell Therapy Products Global Autologous Cell Therapy Products Sales by Region: 2018-2029
3.2.1 Global Autologous Cell Therapy Products Sales by Region: 2018-2024
3.2.2 Global Autologous Cell Therapy Products Sales by Region: 2024-2029
3.3 Global Autologous Cell Therapy Products Global Autologous Cell Therapy Products Revenue by Region: 2018-2029
3.3.1 Global Autologous Cell Therapy Products Revenue by Region: 2018-2024
3.3.2 Global Autologous Cell Therapy Products Revenue by Region: 2024-2029
3.4 North America Autologous Cell Therapy Products Market Facts & Figures by Country
3.4.1 North America Autologous Cell Therapy Products Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Autologous Cell Therapy Products Sales by Country (2018-2029)
3.4.3 North America Autologous Cell Therapy Products Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Autologous Cell Therapy Products Market Facts & Figures by Country
3.5.1 Europe Autologous Cell Therapy Products Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Autologous Cell Therapy Products Sales by Country (2018-2029)
3.5.3 Europe Autologous Cell Therapy Products Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autologous Cell Therapy Products Market Facts & Figures by Country
3.6.1 Asia Pacific Autologous Cell Therapy Products Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Autologous Cell Therapy Products Sales by Country (2018-2029)
3.6.3 Asia Pacific Autologous Cell Therapy Products Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Autologous Cell Therapy Products Market Facts & Figures by Country
3.7.1 Latin America Autologous Cell Therapy Products Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Autologous Cell Therapy Products Sales by Country (2018-2029)
3.7.3 Latin America Autologous Cell Therapy Products Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autologous Cell Therapy Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Autologous Cell Therapy Products Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Autologous Cell Therapy Products Sales by Country (2018-2029)
3.8.3 Middle East and Africa Autologous Cell Therapy Products Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Autologous Cell Therapy Products Sales by Type (2018-2029)
4.1.1 Global Autologous Cell Therapy Products Sales by Type (2018-2024)
4.1.2 Global Autologous Cell Therapy Products Sales by Type (2024-2029)
4.1.3 Global Autologous Cell Therapy Products Sales Market Share by Type (2018-2029)
4.2 Global Autologous Cell Therapy Products Revenue by Type (2018-2029)
4.2.1 Global Autologous Cell Therapy Products Revenue by Type (2018-2024)
4.2.2 Global Autologous Cell Therapy Products Revenue by Type (2024-2029)
4.2.3 Global Autologous Cell Therapy Products Revenue Market Share by Type (2018-2029)
4.3 Global Autologous Cell Therapy Products Price by Type (2018-2029)
5 Segment by Application
5.1 Global Autologous Cell Therapy Products Sales by Application (2018-2029)
5.1.1 Global Autologous Cell Therapy Products Sales by Application (2018-2024)
5.1.2 Global Autologous Cell Therapy Products Sales by Application (2024-2029)
5.1.3 Global Autologous Cell Therapy Products Sales Market Share by Application (2018-2029)
5.2 Global Autologous Cell Therapy Products Revenue by Application (2018-2029)
5.2.1 Global Autologous Cell Therapy Products Revenue by Application (2018-2024)
5.2.2 Global Autologous Cell Therapy Products Revenue by Application (2024-2029)
5.2.3 Global Autologous Cell Therapy Products Revenue Market Share by Application (2018-2029)
5.3 Global Autologous Cell Therapy Products Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Novartis Autologous Cell Therapy Products Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Corporation Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Gilead Sciences Autologous Cell Therapy Products Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Corporation Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Bristol-Myers Squibb Autologous Cell Therapy Products Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Johnson & Johnson Autologous Cell Therapy Products Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Autolus Therapeutics
6.5.1 Autolus Therapeutics Corporation Information
6.5.2 Autolus Therapeutics Description and Business Overview
6.5.3 Autolus Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Autolus Therapeutics Autologous Cell Therapy Products Product Portfolio
6.5.5 Autolus Therapeutics Recent Developments/Updates
6.6 FOSUNKite
6.6.1 FOSUNKite Corporation Information
6.6.2 FOSUNKite Description and Business Overview
6.6.3 FOSUNKite Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.6.4 FOSUNKite Autologous Cell Therapy Products Product Portfolio
6.6.5 FOSUNKite Recent Developments/Updates
6.7 JW Therapeutics
6.6.1 JW Therapeutics Corporation Information
6.6.2 JW Therapeutics Description and Business Overview
6.6.3 JW Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.4.4 JW Therapeutics Autologous Cell Therapy Products Product Portfolio
6.7.5 JW Therapeutics Recent Developments/Updates
6.8 CARsgen Therapeutics
6.8.1 CARsgen Therapeutics Corporation Information
6.8.2 CARsgen Therapeutics Description and Business Overview
6.8.3 CARsgen Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.8.4 CARsgen Therapeutics Autologous Cell Therapy Products Product Portfolio
6.8.5 CARsgen Therapeutics Recent Developments/Updates
6.9 Sorrento Therapeutics
6.9.1 Sorrento Therapeutics Corporation Information
6.9.2 Sorrento Therapeutics Description and Business Overview
6.9.3 Sorrento Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Sorrento Therapeutics Autologous Cell Therapy Products Product Portfolio
6.9.5 Sorrento Therapeutics Recent Developments/Updates
6.10 Mustang Bio
6.10.1 Mustang Bio Corporation Information
6.10.2 Mustang Bio Description and Business Overview
6.10.3 Mustang Bio Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Mustang Bio Autologous Cell Therapy Products Product Portfolio
6.10.5 Mustang Bio Recent Developments/Updates
6.11 Cellectis
6.11.1 Cellectis Corporation Information
6.11.2 Cellectis Autologous Cell Therapy Products Description and Business Overview
6.11.3 Cellectis Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Cellectis Autologous Cell Therapy Products Product Portfolio
6.11.5 Cellectis Recent Developments/Updates
6.12 Allogene Therapeutics
6.12.1 Allogene Therapeutics Corporation Information
6.12.2 Allogene Therapeutics Autologous Cell Therapy Products Description and Business Overview
6.12.3 Allogene Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Allogene Therapeutics Autologous Cell Therapy Products Product Portfolio
6.12.5 Allogene Therapeutics Recent Developments/Updates
6.13 Celyad Oncology
6.13.1 Celyad Oncology Corporation Information
6.13.2 Celyad Oncology Autologous Cell Therapy Products Description and Business Overview
6.13.3 Celyad Oncology Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Celyad Oncology Autologous Cell Therapy Products Product Portfolio
6.13.5 Celyad Oncology Recent Developments/Updates
6.14 Bluebird Bio
6.14.1 Bluebird Bio Corporation Information
6.14.2 Bluebird Bio Autologous Cell Therapy Products Description and Business Overview
6.14.3 Bluebird Bio Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Bluebird Bio Autologous Cell Therapy Products Product Portfolio
6.14.5 Bluebird Bio Recent Developments/Updates
6.15 Lonza
6.15.1 Lonza Corporation Information
6.15.2 Lonza Autologous Cell Therapy Products Description and Business Overview
6.15.3 Lonza Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Lonza Autologous Cell Therapy Products Product Portfolio
6.15.5 Lonza Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autologous Cell Therapy Products Industry Chain Analysis
7.2 Autologous Cell Therapy Products Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autologous Cell Therapy Products Production Mode & Process
7.4 Autologous Cell Therapy Products Sales and Marketing
7.4.1 Autologous Cell Therapy Products Sales Channels
7.4.2 Autologous Cell Therapy Products Distributors
7.5 Autologous Cell Therapy Products Customers
8 Autologous Cell Therapy Products Market Dynamics
8.1 Autologous Cell Therapy Products Industry Trends
8.2 Autologous Cell Therapy Products Market Drivers
8.3 Autologous Cell Therapy Products Market Challenges
8.4 Autologous Cell Therapy Products Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Autologous Cell Therapy Products Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Autologous Cell Therapy Products Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Autologous Cell Therapy Products Market Competitive Situation by Manufacturers in 2022
Table 4. Global Autologous Cell Therapy Products Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Autologous Cell Therapy Products Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Autologous Cell Therapy Products Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Autologous Cell Therapy Products Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Autologous Cell Therapy Products Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Autologous Cell Therapy Products, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Autologous Cell Therapy Products, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Autologous Cell Therapy Products, Product Type & Application
Table 12. Global Key Manufacturers of Autologous Cell Therapy Products, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Autologous Cell Therapy Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Cell Therapy Products as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Autologous Cell Therapy Products Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Autologous Cell Therapy Products Sales by Region (2018-2024) & (K Units)
Table 18. Global Autologous Cell Therapy Products Sales Market Share by Region (2018-2024)
Table 19. Global Autologous Cell Therapy Products Sales by Region (2024-2029) & (K Units)
Table 20. Global Autologous Cell Therapy Products Sales Market Share by Region (2024-2029)
Table 21. Global Autologous Cell Therapy Products Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Autologous Cell Therapy Products Revenue Market Share by Region (2018-2024)
Table 23. Global Autologous Cell Therapy Products Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Autologous Cell Therapy Products Revenue Market Share by Region (2024-2029)
Table 25. North America Autologous Cell Therapy Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 27. North America Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 28. North America Autologous Cell Therapy Products Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Autologous Cell Therapy Products Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Autologous Cell Therapy Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 32. Europe Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 33. Europe Autologous Cell Therapy Products Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Autologous Cell Therapy Products Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Autologous Cell Therapy Products Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Autologous Cell Therapy Products Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Autologous Cell Therapy Products Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Autologous Cell Therapy Products Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Autologous Cell Therapy Products Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Autologous Cell Therapy Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Autologous Cell Therapy Products Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Autologous Cell Therapy Products Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Autologous Cell Therapy Products Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Autologous Cell Therapy Products Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Autologous Cell Therapy Products Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Autologous Cell Therapy Products Sales (K Units) by Type (2018-2024)
Table 51. Global Autologous Cell Therapy Products Sales (K Units) by Type (2024-2029)
Table 52. Global Autologous Cell Therapy Products Sales Market Share by Type (2018-2024)
Table 53. Global Autologous Cell Therapy Products Sales Market Share by Type (2024-2029)
Table 54. Global Autologous Cell Therapy Products Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Autologous Cell Therapy Products Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Autologous Cell Therapy Products Revenue Market Share by Type (2018-2024)
Table 57. Global Autologous Cell Therapy Products Revenue Market Share by Type (2024-2029)
Table 58. Global Autologous Cell Therapy Products Price (US$/Unit) by Type (2018-2024)
Table 59. Global Autologous Cell Therapy Products Price (US$/Unit) by Type (2024-2029)
Table 60. Global Autologous Cell Therapy Products Sales (K Units) by Application (2018-2024)
Table 61. Global Autologous Cell Therapy Products Sales (K Units) by Application (2024-2029)
Table 62. Global Autologous Cell Therapy Products Sales Market Share by Application (2018-2024)
Table 63. Global Autologous Cell Therapy Products Sales Market Share by Application (2024-2029)
Table 64. Global Autologous Cell Therapy Products Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Autologous Cell Therapy Products Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Autologous Cell Therapy Products Revenue Market Share by Application (2018-2024)
Table 67. Global Autologous Cell Therapy Products Revenue Market Share by Application (2024-2029)
Table 68. Global Autologous Cell Therapy Products Price (US$/Unit) by Application (2018-2024)
Table 69. Global Autologous Cell Therapy Products Price (US$/Unit) by Application (2024-2029)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Novartis Autologous Cell Therapy Products Product
Table 74. Novartis Recent Developments/Updates
Table 75. Gilead Sciences Corporation Information
Table 76. Gilead Sciences Description and Business Overview
Table 77. Gilead Sciences Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Gilead Sciences Autologous Cell Therapy Products Product
Table 79. Gilead Sciences Recent Developments/Updates
Table 80. Bristol-Myers Squibb Corporation Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Bristol-Myers Squibb Autologous Cell Therapy Products Product
Table 84. Bristol-Myers Squibb Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Johnson & Johnson Autologous Cell Therapy Products Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. Autolus Therapeutics Corporation Information
Table 91. Autolus Therapeutics Description and Business Overview
Table 92. Autolus Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Autolus Therapeutics Autologous Cell Therapy Products Product
Table 94. Autolus Therapeutics Recent Developments/Updates
Table 95. FOSUNKite Corporation Information
Table 96. FOSUNKite Description and Business Overview
Table 97. FOSUNKite Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. FOSUNKite Autologous Cell Therapy Products Product
Table 99. FOSUNKite Recent Developments/Updates
Table 100. JW Therapeutics Corporation Information
Table 101. JW Therapeutics Description and Business Overview
Table 102. JW Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. JW Therapeutics Autologous Cell Therapy Products Product
Table 104. JW Therapeutics Recent Developments/Updates
Table 105. CARsgen Therapeutics Corporation Information
Table 106. CARsgen Therapeutics Description and Business Overview
Table 107. CARsgen Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. CARsgen Therapeutics Autologous Cell Therapy Products Product
Table 109. CARsgen Therapeutics Recent Developments/Updates
Table 110. Sorrento Therapeutics Corporation Information
Table 111. Sorrento Therapeutics Description and Business Overview
Table 112. Sorrento Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Sorrento Therapeutics Autologous Cell Therapy Products Product
Table 114. Sorrento Therapeutics Recent Developments/Updates
Table 115. Mustang Bio Corporation Information
Table 116. Mustang Bio Description and Business Overview
Table 117. Mustang Bio Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Mustang Bio Autologous Cell Therapy Products Product
Table 119. Mustang Bio Recent Developments/Updates
Table 120. Cellectis Corporation Information
Table 121. Cellectis Description and Business Overview
Table 122. Cellectis Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Cellectis Autologous Cell Therapy Products Product
Table 124. Cellectis Recent Developments/Updates
Table 125. Allogene Therapeutics Corporation Information
Table 126. Allogene Therapeutics Description and Business Overview
Table 127. Allogene Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Allogene Therapeutics Autologous Cell Therapy Products Product
Table 129. Allogene Therapeutics Recent Developments/Updates
Table 130. Celyad Oncology Corporation Information
Table 131. Celyad Oncology Description and Business Overview
Table 132. Celyad Oncology Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Celyad Oncology Autologous Cell Therapy Products Product
Table 134. Celyad Oncology Recent Developments/Updates
Table 135. Bluebird Bio Corporation Information
Table 136. Bluebird Bio Description and Business Overview
Table 137. Bluebird Bio Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Bluebird Bio Autologous Cell Therapy Products Product
Table 139. Bluebird Bio Recent Developments/Updates
Table 140. Lonza Corporation Information
Table 141. Lonza Description and Business Overview
Table 142. Lonza Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Lonza Autologous Cell Therapy Products Product
Table 144. Lonza Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Autologous Cell Therapy Products Distributors List
Table 148. Autologous Cell Therapy Products Customers List
Table 149. Autologous Cell Therapy Products Market Trends
Table 150. Autologous Cell Therapy Products Market Drivers
Table 151. Autologous Cell Therapy Products Market Challenges
Table 152. Autologous Cell Therapy Products Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Autologous Cell Therapy Products
Figure 2. Global Autologous Cell Therapy Products Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Autologous Cell Therapy Products Market Share by Type in 2022 & 2029
Figure 4. Autologous Stem Cell Transplants Product Picture
Figure 5. Autologous T Cell Therapies Product Picture
Figure 6. Platelet-Rich Plasma (PRP) Therapy Product Picture
Figure 7. Others Product Picture
Figure 8. Global Autologous Cell Therapy Products Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Autologous Cell Therapy Products Market Share by Application in 2022 & 2029
Figure 10. Cancer
Figure 11. Hemophilia
Figure 12. Others
Figure 13. Global Autologous Cell Therapy Products Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Autologous Cell Therapy Products Market Size (2018-2029) & (US$ Million)
Figure 15. Global Autologous Cell Therapy Products Sales (2018-2029) & (K Units)
Figure 16. Global Autologous Cell Therapy Products Average Price (US$/Unit) & (2018-2029)
Figure 17. Autologous Cell Therapy Products Report Years Considered
Figure 18. Autologous Cell Therapy Products Sales Share by Manufacturers in 2022
Figure 19. Global Autologous Cell Therapy Products Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Autologous Cell Therapy Products Players: Market Share by Revenue in 2022
Figure 21. Autologous Cell Therapy Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Autologous Cell Therapy Products Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America Autologous Cell Therapy Products Sales Market Share by Country (2018-2029)
Figure 24. North America Autologous Cell Therapy Products Revenue Market Share by Country (2018-2029)
Figure 25. United States Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Autologous Cell Therapy Products Sales Market Share by Country (2018-2029)
Figure 28. Europe Autologous Cell Therapy Products Revenue Market Share by Country (2018-2029)
Figure 29. Germany Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific Autologous Cell Therapy Products Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific Autologous Cell Therapy Products Revenue Market Share by Region (2018-2029)
Figure 36. China Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Autologous Cell Therapy Products Sales Market Share by Country (2018-2029)
Figure 44. Latin America Autologous Cell Therapy Products Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Autologous Cell Therapy Products Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Autologous Cell Therapy Products Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Autologous Cell Therapy Products Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Autologous Cell Therapy Products by Type (2018-2029)
Figure 54. Global Revenue Market Share of Autologous Cell Therapy Products by Type (2018-2029)
Figure 55. Global Autologous Cell Therapy Products Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Autologous Cell Therapy Products by Application (2018-2029)
Figure 57. Global Revenue Market Share of Autologous Cell Therapy Products by Application (2018-2029)
Figure 58. Global Autologous Cell Therapy Products Price (US$/Unit) by Application (2018-2029)
Figure 59. Autologous Cell Therapy Products Value Chain
Figure 60. Autologous Cell Therapy Products Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed